https://doctransparency.com/doctor/tx/houston/george-atallah-1093940694
Medicare Enrolled

Dr. George Atallah, D.O.

Anesthesiology · Houston, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
902 FROSTWOOD DR STE 235, Houston, TX 77024
7132980120
In practice since 2009 (16 years)
NPI: 1093940694 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Atallah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Atallah? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Atallah

Dr. George Atallah is an anesthesiology in Houston, TX, with 16 years in practice. Based on federal Medicare data, Dr. Atallah performed 4,680 Medicare services across 842 unique beneficiaries.

Between the years covered by Open Payments, Dr. Atallah received a total of $61,728 from 71 pharmaceutical and/or device companies across 1060 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in anesthesiology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Atallah is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice▲ Top 2% volume in TX$ $61,728 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,680
Medicare services
Top 2% in TX for anesthesiology
842
Unique beneficiaries
$53
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~292 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Steroid injection (triamcinolone)1,517$1$5
Office visit, established patient (30-39 min)1,361$98$405
Testing for presence of drug, read by direct observation321$12$40
Dexamethasone injection (steroid)230$0$1
Joint injection, major joint186$55$200
Compounded drug, not otherwise classified179$157$525
Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician161$74$380
Limited ultrasound scan of abdomen159$69$285
Injection, ketorolac tromethamine, per 15 mg156$0$1
Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose81$100$650
Injection of trigger points, 3 or more muscles70$46$195
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level55$234$790
Injection of substance into lower spine canal using imaging guidance39$205$845
New patient office visit (45-59 min)39$123$520
Injection of anesthetic agent and/or steroid into suprascapular shoulder nerve34$70$280
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level31$94$355
Electronic analysis and reprogramming of spinal canal drug infusion pump28$34$140
Injection of lower or sacral spine facet joint using imaging guidance, single level17$183$565
Injection of lower or sacral spine facet joint using imaging guidance, second level16$99$290
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.0% high complexity
55.4% medium
40.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$61,728
Total received (2018-2024)
Avg $8,818/year across 7 years
Top 1% in TX for anesthesiology
71
Companies
1,060
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$44,179 (71.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,549 (28.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$5,497
2023
$6,252
2022
$4,642
2021
$2,546
2020
$5,317
2019
$21,264
2018
$16,212

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medtronic USA, Inc.
$32,784
Medtronic, Inc.
$8,683
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$4,381
Nevro Corp.
$3,583
Abbott Laboratories
$1,022
Collegium Pharmaceutical, Inc.
$1,015
PFIZER INC.
$846
Boston Scientific Corporation
$737
ABBVIE INC.
$654
Flexion Therapeutics, Inc.
$594
AbbVie Inc.
$537
Allergan, Inc.
$405
Biohaven Pharmaceutical Holding Company Ltd.
$378
PAINTEQ LLC
$371
Scilex Pharmaceuticals Inc.
$352
Lilly USA, LLC
$317
Horizon Therapeutics plc
$282
TerSera Therapeutics LLC
$257
Almatica Pharma LLC
$253
IMPEL PHARMACEUTICALS INC.
$253
Allergan Inc.
$245
BioDelivery Sciences International, Inc.
$240
ARBOR PHARMACEUTICALS, INC.
$237
Eisai Inc.
$234
SCILEX PHARMACEUTICALS INC.
$230
Pacira Therapeutics, Inc.
$229
BOSTON SCIENTIFIC CORPORATION
$180
Azurity Pharmaceuticals, Inc.
$171
Supernus Pharmaceuticals, Inc.
$163
Saluda Medical Americas, Inc.
$142
GRT US Holding, Inc.
$139
Amgen Inc.
$119
RedHill Biopharma Inc.
$117
Vertos Medical, Inc.
$99
Relievant Medsystems, Inc.
$98
Novartis Pharmaceuticals Corporation
$98
Arbor Pharmaceuticals, Inc.
$81
Averitas Pharma Inc.
$79
IDORSIA PHARMACEUTICALS US INC
$79
Zyla Life Sciences
$77
Assertio Therapeutics, Inc.
$72
Teva Pharmaceuticals USA, Inc.
$62
ASSERTIO THERAPEUTICS, Inc.
$61
Daiichi Sankyo Inc.
$50
Nuvectra Corporation
$48
SI-BONE, Inc.
$43
Horizon Pharma plc
$43
Pacira Pharmaceuticals Incorporated
$43
AstraZeneca Pharmaceuticals LP
$41
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$39
Fidia Pharma USA Inc.
$37
Bioventus LLC
$36
Biohaven Pharmaceuticals, Inc.
$34
Pernix Therapeutics Holdings, Inc.
$31
Egalet US Inc
$30
US WorldMeds, LLC
$24
Vertical Pharmaceuticals, LLC
$23
Innovation Technologies Inc
$22
Nalu Medical, Inc.
$22
Spinal Simplicity, LLC
$21
Bausch Health US, LLC
$20
Curonix LLC
$20
Shionogi Inc
$20
Vertiflex, Inc.
$19
Takeda Pharmaceuticals U.S.A., Inc.
$18
Upsher-Smith Laboratories LLC
$17
DePuy Synthes Sales Inc.
$15
Currax Pharmaceuticals LLC
$15
Zyla Life Sciences, Inc.
$15
Medtronic Vascular, Inc.
$14
Stimwave Technologies Incorporated
$14
Top 3 companies account for 74.3% of total payments
Associated products mentioned in payments ›
ACCURIAN · ADAPTIVESTIM · AIMOVIG · AJOVY · ASCENDA · AUTOFILL · Accurian · Aemcolo · Aimovig · Algovita · Amitiza · Axium Sheath Braided DRG · BELBUCA · BOTOX · BOTOX THERAPEUTIC · BUNAVAIL · BUNAVAIL 2.1 mg 30-count box · Belbuca · COMIRNATY · CONTRAVE · Cambia · ClosureFast · DUEXIS · Dayvigo · Durolane · EMGALITY · ETERNA · Evoke · Evoke SCS · Exparel · GENERAL PAIN MANAGEMENT · GENERAL THERAPIES · GRALISE · Gralise · HA MINUTEMAN G3-R · HORIZANT · HYMOVIS · Horizant · INFINION · INTELLIS · INTELLIS ADAPTIVESTIM · IRRISEPT · Intracept · LORZONE · LUCEMYRA · LYRICA · Lucemyra/Lofexidine · MIGRANAL · MOVANTIK · MYSTIM · Morphabond ER · Movantik · NAPRELAN · NURTEC ODT · Nalu Neurostimulation System · Nucynta · ORTHOVISC · Omnia · PAINTEQ · PENNSAID · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PRIALT · PROCLAIM · PlasmaBlade · Prialt · Proclaim Family of SCS IPGs · Proclaim IPG · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · QUVIVIQ · Qutenza · RAYOS · RELISTOR · RELISTOR ORAL · RESTORE · REYVOW · SPECTRA WAVEWRITER · SPRIX · SUPERION · SYNCHROMED · SYNCHROMEDII · Senza · Senza Spinal Cord Stimulation System · Superion ISS · Superion Indirect Decompression System · Symproic · TROKENDI XR · Talicia · Trudhesa · UBRELVY · V-LOC 180 · VANTA ADAPTIVESTIM · VECTRIS · VIMOVO · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · Zipsor · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (72%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in anesthesiology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for anesthesiology in TX.

Equivalent to $1,319 per 100 Medicare services performed
Looking for a anesthesiology in Houston?
Compare anesthesiologys in the Houston area by procedure volume, costs, and industry payment transparency.
Browse anesthesiologys nearby

Geographic Context

Anesthesiologys within 10 mi
1,093
Per 100K population
23.0
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN MEMORIAL CITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Atallah is a clinical cardiology specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (speaking/promotional, top 1%), with 16 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Atallah experienced with steroid injection (triamcinolone)?
Based on Medicare claims data, Dr. Atallah performed 1,517 steroid injection (triamcinolone) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Atallah receive payments from pharmaceutical companies?
Yes. Dr. Atallah received a total of $61,728 from 71 companies across 1,060 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Atallah's costs compare to other anesthesiologys in Houston?
Dr. Atallah's average Medicare payment per service is $53. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Atallah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →